• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Rosie Riley, USA

    Rosie Riley, USA

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Anna Barrow, UK

    Anna Barrow, UK

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Ann Nicol, USA

    Ann Nicol, USA

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Jean

    Jean
    jean

  • Daniel Hare, USA

    Daniel Hare, USA

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Liam Dwyer, England

    Liam Dwyer, England

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Olga, Argentina

    Olga, Argentina

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Alex, Argentina

    Alex, Argentina

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Willi Klein, UK

    Willi Klein, UK

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Rob Tison, USA

    Rob Tison, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Bayley, Australia

    Bayley, Australia

  • Philip Brindle, England

    Philip Brindle, England

  • Chris McCauley, Canada

    Chris McCauley, Canada

Learn more about the March of Faces

Footer

Subscribe to our Bi-monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login